In this issue:
Neoadjuvant CROSS regimen effective for resectable adenocarcinoma
Immediate palliative treatment is best for asymptomatic metastatic disease
DFS validated as a surrogate for OS in oesophageal cancer
Immunotherapy combo promising for MSI-H gastric/GEJ cancer
Radiomics data enhances prognostic models
Is esophagectomy safe in elderly patients?
Most adenocarcinomas have at least one therapeutically targetable molecule
ctDNA analysis may predict postsurgical recurrence in oesophageal SCC
Adjuvant therapy for oesophageal SCC may only benefit non-pCR patients
NSE and ProGRP are promising biomarkers for small cell oesophageal carcinoma
Please login below to download this issue (PDF)